Palomino Laboratories Income Statement (2022-2025) | PALX

Income Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Selling, General & Administrative (Quarter) 0.00M0.00M0.04M0.03M0.05M0.03M0.00M0.14M0.05M0.04M1.60M-1.93M
Operating Expenses (Quarter) 0.00M0.00M0.04M0.03M0.05M0.03M0.00M0.14M0.05M0.04M1.60M-1.93M
Operating Income (Quarter) -0.04M-0.03M-0.05M-0.03M-0.00M-0.14M-0.05M-0.04M-1.60M
EBIT (Quarter) -0.04M-0.03M-0.05M-0.03M-0.00M-0.14M-0.05M-0.04M-1.60M
Non-operating items
Interest & Investment Income (Quarter) 0.00M37.00
Non Operating Income (Quarter) 0.00M975.00
Net income details
EBT (Quarter) -0.04M-0.03M-0.05M-0.03M116.00-0.14M-0.06M-0.04M-1.60M
Profit After Tax (Quarter) -0.00M-0.00M-0.04M-0.03M-247.00346.00-0.01M-0.14M-0.99M0.39M-1.82M
Income from Continuing Operations (Quarter) -0.04M-0.03M-0.05M-0.03M116.00-0.14M-0.06M-0.04M-1.60M
Consolidated Net Income (Quarter) -0.04M-0.03M-0.05M-0.03M116.00-0.14M-0.06M-0.04M-1.60M
Income towards Parent Company (Quarter) -0.04M-0.03M-0.05M-0.03M116.00-0.14M-0.06M-0.04M-1.60M
Net Income towards Common Stockholders (Quarter) -0.04M-0.03M-0.05M-0.03M116.00-0.14M-0.06M-0.04M-1.60M
Additional items
EPS (Basic) (Quarter) 0.000.00-0.01-0.01-0.01-0.010.00-0.01-0.01-0.01-0.540.41
EPS (Weighted Average and Diluted) (Quarter) 0.000.00-0.01-0.01-0.01-0.010.00-0.01-0.01-0.01-0.540.41
Shares Outstanding (Weighted Average) (Quarter) 5.00M5.00M5.00M5.00M5.00M5.00M5.00M1.66M1.52M5.00M5.00M7.49M6.71M
Shares Outstanding (Diluted Average) (Quarter) 5.00M5.00M5.00M5.00M5.00M5.00M5.00M1.38M1.52M5.00M5.00M2.74M6.71M
EBITDA (Quarter) -0.04M-0.03M-0.05M-0.03M-0.00M-0.14M-0.05M-0.04M-1.60M
Interest Expenses (Quarter) 0.01M0.01M